25Serious

Valérie Masson-Delmotte

Valérie Masson-Delmotte

Ask VT AI

View News Summary

Former Jets center Nick Mangold, a seven-time Pro Bowler, dies at 41 from complications of chronic kidney disease.
Controversial officiating in Eagles-Giants game sparks calls to revisit 'tush push' rule
Novartis nears $12B acquisition of Avidity Biosciences, a biotech with a platform for delivering RNA therapeutics to muscle tissue.

20 hours

United States Politics

Discover the latest news, candidates,  and key topics of US politics

Latest News

Valérie Masson-Delmotte

Scientists Warn Polar Geoengineering Risks Worsening Arctic Climate

100% center coverage1 source

Valérie Masson-Delmotte

Scientists Warn Polar Geoengineering Risks Worsening Arctic Climate

100% center coverage1 source

Scientists Warn Polar Geoengineering Risks Worsening Arctic Climate

Scientists Warn Polar Geoengineering Risks Worsening Arctic Climate

Valérie Masson-Delmotte

Scientists Warn Polar Geoengineering Proposals Pose High Costs, Environmental Risks

50% left coverage2 sources

Valérie Masson-Delmotte

Scientists Warn Polar Geoengineering Proposals Pose High Costs, Environmental Risks

50% left coverage2 sources

Scientists Warn Polar Geoengineering Proposals Pose High Costs, Environmental Risks

Scientists Warn Polar Geoengineering Proposals Pose High Costs, Environmental Risks

Valérie Masson-Delmotte, Climate Change

Scientists Declare 2°C Climate Goal Impossible, Warn of Severe Warming

100% left coverage2 sources

Valérie Masson-Delmotte, Climate Change

Scientists Declare 2°C Climate Goal Impossible, Warn of Severe Warming

100% left coverage2 sources

Scientists Declare 2°C Climate Goal Impossible, Warn of Severe Warming

Scientists Declare 2°C Climate Goal Impossible, Warn of Severe Warming

Ask VT AI

View News Summary

Former Jets center Nick Mangold, a seven-time Pro Bowler, dies at 41 from complications of chronic kidney disease.
Controversial officiating in Eagles-Giants game sparks calls to revisit 'tush push' rule
Novartis nears $12B acquisition of Avidity Biosciences, a biotech with a platform for delivering RNA therapeutics to muscle tissue.

20 hours

United States Politics

Discover the latest news, candidates,  and key topics of US politics

Most Reported By
News from Valérie Masson-Delmotte